Platelet activation in chronic cocaine users: Effect of short term abstinence

Platelets

Volumn 22, Issue 8, 2011, Pages 596-601

  Pereira, Jaime ^a   Sáez, Claudia G ^a   Pallavicini, Julio ^b   Panes, Olga ^a   Pereira Flores, Karla ^a   Cabreras, Manuel J ^a   Massardo, Teresa ^b   Mezzano, Diego ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

Author keywords

Atherosclrosis; Cocaine; Platelet activation; Platelet chemokines

Indexed keywords

BENZODIAZEPINE; CD40 LIGAND; CHEMOKINE; COCAINE; NEUTROPHIL ACTIVATING PEPTIDE 2; RANTES; RISPERIDONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DRUG EXPOSURE; DRUG USE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; URINALYSIS; WITHDRAWAL SYNDROME;

ADULT; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; CD40 LIGAND; CELL AGGREGATION; COCAINE; COCAINE-RELATED DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; PLATELET ACTIVATION; PLATELET AGGREGATION; YOUNG ADULT;

EID: 80455144993     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2011.578181     Document Type: Article

References (30)

1. Substance Abuse and Mental Health Services Administration OoAS. Results from the 2007 national survey on drug use and health: National findings Rockville: NSDUH Series H-34, DHHS Publication No. SMA 08-4343, 2008.
2. McCord J, Jneid H, Hollander JE, de Lemos JA, Cercek B, Hsue P, Gibler WB, Ohman EM, Drew B, Philippides G, et al. Management of cocaine-associated chest pain and myocardial infarction: A scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008;117:1897-1907. (Pubitemid 351507480)
3. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001;345:351-358. (Pubitemid 32703239)
4. Lange RA, Cigarroa RG, Yancy Jr CW, Willard JE, Popma JJ, Sills MN, McBride W, Kim AS, Hillis LD. Cocaine-induced coronary-artery vasoconstriction. N Engl J Med. 1989;321:1557-1562. (Pubitemid 20008233)
5. Benzaquen BS, Cohen V, Eisenberg MJ. Effects of cocaine on the coronary arteries. Am Heart J. 2001;142:402-410. (Pubitemid 32801623)
6. Simpson RW, Edwards WD. Pathogenesis of cocaine-induced ischemic heart disease. Autopsy findings in a 21-year-old man. Arch Pathol Lab Med. 1986;110:479-484. (Pubitemid 16040167)
7. Patrizi R, Pasceri V, Sciahbasi A, Summaria F, Rosano GM, Lioy E. Evidence of cocaine-related coronary atherosclerosis in young patients with myocardial infarction. J Am Coll Cardiol. 2006;47:2120-2122.
8. Lucena J, Blanco M, Jurado C, Rico A, Salguero M, Vazquez R, Thiene G, Basso C. Cocaine-related sudden death: A prospective investigation in south-west Spain. Eur Heart J. 2010;31:318-329.
9. Gawaz M, Favaloro EJ. Platelets, inflammation and cardiovascular diseases. New concepts and therapeutic implications. Semin Thromb Hemost. 2010;36:129-130.
10. Gawaz M. Platelets in the onset of atherosclerosis. Blood Cells Mol Dis. 2006;36:206-210.
11. Thaulow E, Erikssen J, Sandvik L, Stormorken H, Cohn PF. Blood-platelet count and function are related to total and cardiovascular death in apparently healthy men. Circulation. 1991;84:613-617.
12. Willoughby S, Holmes A, Loscalzo J. Platelets and cardiovascular disease. Eur J Cardiovasc Nurs. 2002;1:273-288. (Pubitemid 36857068)
13. Fateh-Moghadam S, Bocksch W, Ruf A, Dickfeld T, Schartl M, Pogatsa-Murray G, Hetzer R, Fleck E, Gawaz M. Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy. Circulation. 2000;102:890-897.
14. Smith NM, Pathansali R, Bath PM. Platelets and stroke. Vasc Med. 1999;4:165-172. (Pubitemid 29426367)
15. Koyama H, Maeno T, Fukumoto S, Shoji T, Yamane T, Yokoyama H, Emoto M, Tahara H, Inaba M, Hino M, et al. Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans. Circulation. 2003;108:524-529. (Pubitemid 36961164)
16. Heesch CM, Wilhelm CR, Ristich J, Adnane J, Bontempo FA, Wagner WR. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart. 2000;83:688-695. (Pubitemid 30345974)
17. Rinder HM, Ault KA, Jatlow PI, Kosten TR, Smith BR. Platelet alpha-granule release in cocaine users. Circulation. 1994;90:1162-1167.
18. Jennings LK, White MM, Sauer CM, Mauer AM, Robertson JT. Cocaine-induced platelet defects. Stroke. 1993;24:1352-1359. (Pubitemid 23254639)
19. Heesch CM, Negus BH, Steiner M, Snyder II RW, McIntire DD, Grayburn PA, Ashcraft J, Hernandez JA, Eichhorn EJ. Effects of in vivo cocaine administration on human platelet aggregation. Am J Cardiol. 1996;78:237-239. (Pubitemid 26244380)
20. First MB SR, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV axis I disorders. New York: Institute NYSP; 1997.
21. Kellogg SH, McHugh PF, Bell K, Schluger JH, Schluger RP, LaForge KS, Ho A, Kreek MJ. The Kreek-McHugh-Schluger-Kellogg scale: A new, rapid method for quantifying substance abuse and its possible applications. Drug Alcohol Depend. 2003;69:137-150. (Pubitemid 36259776)
22. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: Bridging thrombosis and inflammation. Circulation. 2002;105:2130-2132. (Pubitemid 34517152)
23. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: Linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009;54:669-677.
24. Lievens D, Zernecke A, Seijkens T, Soehnlein O, Beckers L, Munnix IC, Wijnands E, Goossens P, van Kruchten R, Thevissen L, et al. Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood. 2010; 116:4317-4327.
25. Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol. 2008;28:1920-1927.
26. Smith C, Damas JK, Otterdal K, Oie E, Sandberg WJ, Yndestad A, Waehre T, Scholz H, Endresen K, Olofsson PS, Halvorsen B, Gullestad L, Froland SS, Hansson GK, Aukrust P. Increased levels of neutrophil-activating peptide-2 in acute coronary syndromes: Possible role of plateletmediated vascular inflammation. J Am Coll Cardiol. 2006;48:1591-1599. (Pubitemid 44528185)
27. von Hundelshausen P, Weber KS, Huo Y, Proudfoot AE, Nelson PJ, Ley K, Weber C. RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation. 2001;103:1772-1777. (Pubitemid 32291415)
28. Koenen RR, von Hundelshausen P, Nesmelova IV, Zernecke A, Liehn EA, Sarabi A, Kramp BK, Piccinini AM, Paludan SR, Kowalska MA, Kungl AJ, Hackeng TM, Mayo KH, Weber C. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med. 2009;15:97-103.
29. Virani SS, Nambi V, Hoogeveen R, Wasserman BA, Coresh J, Gonzalez II F, Chambless LE, Mosley TH, Boerwinkle E, Ballantyne CM. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: The Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011;32:459-468.
30. Miele GM, Carpenter KM, Smith Cockerham M, Trautman KD, Blaine J, Hasin DS. Substance Dependence Severity Scale (SDSS): Reliability and validity of a clinicianadministered interview for DSM-IV substance use disorders. Drug Alcohol Depend. 2000;59:63-75. (Pubitemid 30116839)